Special Programs

Mapping the Economic DNA of a Genomics Cluster, A San Diego Case Study

1:00 PM–2:15 PM Jun 19, 2017 (America - Los Angeles)

Room 9, Upper Level


Global pioneers of genetic research have converged with top academic institutions and a culture of entrepreneurship to push the boundaries of DNA-driven medicines, diagnostics and sustainable technologies. In doing so, an ecosystem has evolved that has enabled acceleration in the field, driving new research, discoveries, companies, services, and treatments. In 2000, J. Craig Venter was the first to map the entire human as part of a broad international science initiative. Venter’s multiple companies, alongside the launch of sequencing company Illumina in 1998, set the foundation for San Diego to become a trailblazer in the field. Today, the region’s dozens of genomics companies and more than 80 research institutes, including the J. Craig Venter Institute, lead many to call San Diego “the capital of genomics.” Yet there has never been a wide-spread, data-driven study that tells the story of San Diego’s genomics industry and quantifies its economic impact.

The panel will serve as the official release of San Diego’s regional genomics impact study, a collaborative industry-wide effort to better understand and quantify San Diego’s genomics industry. The study will demonstrate the state of the industry, including employment, number of firms, and the available talent pool of genomics professionals. It will also look at the genomics industry in the broader context of the life sciences community by highlighting other related industries with a strong genomics focus. Behind the data is a story of how this once nascent technology is now shaping the future of global medicine and discovery, but also how it has altered the DNA of an entire region, now known as one of the world’s preeminent genomics hubs. Finally, the study will serve as an impetus to help the global life sciences community better quantify its impact and tell its story. As the first U.S. city to attempt to measure its genomics industry, San Diego has developed a replicable methodology and index that will allow for regional comparisons of genomics clusters.

Session ID: 25123